LTFS
ARIA

Ladenburg Thalmann Financial Services’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-39,602
Closed -$492K – 5129
2016
Q4 		$492K Buy
39,602
+727
+2% +$8.76K 0.01% 1262
2016
Q3 		$533K Hold
38,875
– – 0.01% 1160
2016
Q2 		$287K Sell
38,875
-5,750
-13% -$43.1K ﹤0.01% 1446
2016
Q1 		$285K Sell
44,625
-3,778
-8% -$21.2K 0.01% 1378
2015
Q4 		$302K Buy
48,403
+3,917
+9% +$25.7K 0.01% 1312
2015
Q3 		$260K Sell
44,486
-2,422
-5% -$18.7K 0.01% 1313
2015
Q2 		$388K Buy
46,908
+1,100
+2% +$9.73K 0.01% 1189
2015
Q1 		$378K Sell
45,808
-1,250
-3% -$9.24K 0.01% 1188
2014
Q4 		$324K Buy
47,058
+1,700
+4% +$10.6K 0.01% 1143
2014
Q3 		$245K Buy
45,358
+29,516
+186% +$172K 0.01% 1116
2014
Q2 		$101K Sell
15,842
-20,047
-56% -$138K ﹤0.01% 1601
2014
Q1 		$289K Buy
35,889
+2,297
+7% +$17.9K 0.01% 953
2013
Q4 		$229K Buy
33,592
+23,865
+245% +$129K 0.01% 1010
2013
Q3 		$179K Sell
9,727
-20
-0.2% -$388 0.01% 1058
2013
Q2 		$171K Buy
+9,747
New +$173K 0.01% 1052

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ARIA Position: Q1 2017 in Review

Ladenburg Thalmann Financial Services sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 39,602 shares — an estimated $492K sold.

Ladenburg Thalmann Financial Services first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $533K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Ladenburg Thalmann Financial Services reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 39,602 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $492K.
  • Ladenburg Thalmann Financial Services first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Ladenburg Thalmann Financial Services's Ariad Pharmaceuticals Inc position peaked at $533K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2017, filed 15 May 2017.